Haemonetics CEO Christopher Simon's 2022 pay rises 1% to $8.7M
Haemonetics reports 2022 executive compensation
By ExecPay News
Published: June 17, 2022
Haemonetics reported fiscal year 2022 executive compensation information on June 17, 2022.
In 2022, five executives at Haemonetics received on average a compensation package of $4M, a 23% increase compared to previous year.
Average pay of disclosed executives at Haemonetics
Christopher Simon, Chief Executive Officer, received $8.7M in total, which increased by 1% compared to 2021. 61% of Simon's compensation, or $5.3M, was in stock awards. Simon also received $909K in non-equity incentive plan, $1.5M in option awards, $945K in salary, as well as $29K in other compensation.
For fiscal year 2022, the median employee pay was $45,323 at Haemonetics. Therefore, the ratio of Christopher Simon's pay to the median employee pay was 192 to one.
William P. Burke, Chief Financial Officer, received a compensation package of $3.6M, which increased by 53% compared to previous year. 65% of the compensation package, or $2.3M, was in stock awards.
Michelle L. Basil, General Counsel, earned $3.4M in 2022, a 58% increase compared to previous year.
Stewart W. Strong, President, Global Hospital, received $2.5M in 2022.
Josep L. Llorens, Executive Vice President, Global Manufacturing and Supply Chain, earned $2M in 2022, a 38% increase compared to previous year.
Haemonetics' fiscal year ends on April 2.
Related executives
You may also like
Source: SEC filing on June 17, 2022.